Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer


Ozaslan E., Topaloglu U. S. , Inanc M., Erdem U. G. , Demir H., Arpaci E., ...Daha Fazla

JOURNAL OF BUON, cilt.22, ss.863-868, 2017 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 22 Konu: 4
  • Basım Tarihi: 2017
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayıları: ss.863-868

Özet

Purpose: To evaluate the efficacy and adverse events with cetuximab plus FOLFOX administered as second- and third-line therapy in metastatic colorectal cancer (mCRC) patients.